Screener
Vir Biotechnology, Inc. VIR Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Vir Biotechnology, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
FAQ
- What is Vir Biotechnology, Inc.'s return on invested capital?
- Vir Biotechnology, Inc. (VIR) reported return on invested capital of -36.6% in Q2 2026.
- How has Vir Biotechnology, Inc.'s return on invested capital changed year-over-year?
- Vir Biotechnology, Inc.'s return on invested capital increased by 40.4% year-over-year, from -61.4% to -36.6%.
- What is the long-term trend for Vir Biotechnology, Inc.'s return on invested capital?
- Over 4 years (2020 to 2025), Vir Biotechnology, Inc.'s return on invested capital has grown at a -8.7% compound annual growth rate (CAGR), from -89% to -61.8%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Vir Biotechnology, Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude